]>
IRCT2017082016911N4 IRCT 2017-11-03 Vice Chancellor for research, Shiraz University of Medical Sciences Evaluation of the effect of capsule of date palm pollen in infertile women with polycystic ovary syndrome Clinical trial comparison of the effect of capsule of date palm pollen with clomiphene citrate compared with clomiphene citrate only, on the levels of hormones in clomiphene citrate resistant infertile women with polycystic ovary syndrome 2016-11-21 anticipated 100 Complete https://irct.ir/trial/15685 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Randomization with Blocked Randomization Method. 2 Condition 1: Polycystic ovary syndrome. Condition 2: Infertility due to PCO. Intervention 1: Date Palm pollen capsule, 2 grams daily from day 5 to end of the cycle and Clomiphene citrate, 150 ml grams daily from day 5 to 9 of the menstrual cycle. Intervention 2: Placebo 2 grams daily, from day 5 to the end of the cycle and Clomiphene citrate, 150 ml grams daily from day 5 to 9 of the menstrual cycle.
public Maryam Alsadat Hadigheh
Namazi Square
Shiraz Iran (Islamic Republic of) +98 71 3647 4255 maryam.hadigheh@gmail.com Shiraz University of Medical Sciences scientific Bahar Morshed Behbahani
Zand Street
Shiraz Iran (Islamic Republic of) +98 71 3647 4255 morshed_b@sums.ac.ir Shiraz University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: Clomiphene Citrate resistant infertile women with polycystic ovary syndrome Exclusion criteria: Having no desire to cooperate; Having allergy to date palm pollen; Interrupt treatment in ovulation period; Not using Clomiphene or date palm pollen capsule; allergic to date palm pollen; having chronic disease(Heart, respiratory, kidney and digestive diseases); using other herbal drugs that affect infertility 20 years 40 years Female E28.2 N97.0 Polycystic ovarian syndrome Female infertility associated with anovulation Treatment - Drugs Placebo Date Palm pollen capsule, 2 grams daily from day 5 to end of the cycle and Clomiphene citrate, 150 ml grams daily from day 5 to 9 of the menstrual cycle. Placebo 2 grams daily, from day 5 to the end of the cycle and Clomiphene citrate, 150 ml grams daily from day 5 to 9 of the menstrual cycle. Prolactine. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample. Progestrone. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample. Gonadotropines. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample. Testestrone. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample. Vice Chancellor for research, Shiraz University of Medical Sciences Approved 2016-10-09 Ethics committee of Shiraz University of Medical Sciences Zand st. Shiraz Iran (Islamic Republic of)